Announced Mon, 6 Jul · 18:40 IST
Routine compliance filing: share demat confirmation for Apr-Jun 2026 quarter
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.5%1-day move
₹33.00
prior close
₹33.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.2+0.9+2.1+0.8+2.5+5.0+4.5+3.0+5.6+2.1————
Up moveDown movePending
AI summary
Shukra Pharmaceuticals filed a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. Registrar Purva Sharegistry confirmed that share certificates received for dematerialisation from 5 shareholders (totalling 260 shares) during June 2026 were processed, listed on the exchange, and the register of members updated. No new shares were issued, this is purely an administrative confirmation of converting physical shares to electronic form.
Likely market impact
No material impact on stock price or shareholders; standard quarterly compliance disclosure with no business or capital action involved.